{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:12:42Z","timestamp":1780989162895,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T00:00:00Z","timestamp":1602374400000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jbspin.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:45:34Z","timestamp":1548557134000},"page":"562-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pathogenic effects of anti-citrullinated protein antibodies in rheumatoid arthritis \u2013 role for glycosylation"],"prefix":"10.1016","volume":"86","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Coutant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2019.01.005_bib0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0015","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI117969","article-title":"The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies","volume":"95","author":"Sebbag","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8073-2","article-title":"Prevalence of autoantibodies to cyclic citrullinated peptide in patients with rheumatic diseases other than rheumatoid arthritis: a French multicenter study","volume":"34","author":"Fabien","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0025","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","article-title":"Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)","volume":"63","author":"Forslind","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0030","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"R\u00f6nnelid","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0035","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0040","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0045","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.23284","article-title":"Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen","volume":"58","author":"Clavel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/ar1926","article-title":"Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells","volume":"8","author":"Mathsson","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0055","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0060","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2015-208093","article-title":"Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss","volume":"75","author":"Krishnamurthy","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0065","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","article-title":"Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism","volume":"75","author":"Wigerblad","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0075","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.30362","article-title":"Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's)","volume":"63","author":"Espy","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0080","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/art.27414","article-title":"Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid","volume":"62","author":"Scherer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/annrheumdis-2013-203565","article-title":"Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis","volume":"74","author":"Rombouts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0090","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/art.27533","article-title":"Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis","volume":"62","author":"Ercan","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ni.3579","article-title":"Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease","volume":"18","author":"Pfeifle","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0100","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/eji.200737581","article-title":"Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis","volume":"37","author":"Nandakumar","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0105","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1038\/ncomms7651","article-title":"Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss","volume":"6","author":"Harre","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0115","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","article-title":"CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene","volume":"150","author":"Rouvier","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0120","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0125","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.immuni.2012.10.018","article-title":"Human inflammatory dendritic cells induce Th17 cell differentiation","volume":"38","author":"Segura","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrrheum.2016.147","article-title":"Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles","volume":"12","author":"Coutant","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2019.01.005_bib0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41467-017-00662-w","article-title":"A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:25:17Z","timestamp":1761150317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X19300053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1297319X19300053"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.005","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic effects of anti-citrullinated protein antibodies in rheumatoid arthritis \u2013 role for glycosylation","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}